These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29303152)

  • 1. Response of central serous chorioretinopathy evaluated by multimodal retinal imaging.
    Sacconi R; Baldin G; Carnevali A; Querques L; Rabiolo A; Marchini G; Bandello F; Querques G
    Eye (Lond); 2018 Apr; 32(4):734-742. PubMed ID: 29303152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy.
    Rabiolo A; Zucchiatti I; Marchese A; Baldin G; Sacconi R; Montorio D; Cicinelli MV; Querques L; Bandello F; Querques G;
    Eye (Lond); 2018 Jan; 32(1):55-66. PubMed ID: 29265111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Factors of Response to Mineralocorticoid Receptor Antagonists in Nonresolving Central Serous Chorioretinopathy.
    Bousquet E; Dhundass M; Lejoyeux R; Shinojima A; Krivosic V; Mrejen S; Gaudric A; Tadayoni R
    Am J Ophthalmol; 2019 Feb; 198():80-87. PubMed ID: 30308202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Findings of OCT-angiography compared to fluorescein and indocyanine green angiography in central serous chorioretinopathy.
    Min JY; Lv Y; Yu S; Gong YY
    Lasers Surg Med; 2018 Dec; 50(10):987-993. PubMed ID: 29896889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with eplerenone to treat chronic central serous chorioretinopathy.
    Cakir B; Fischer F; Ehlken C; Bühler A; Stahl A; Schlunck G; Böhringer D; Agostini H; Lange C
    Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2151-2157. PubMed ID: 27145785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Outcome During Eplerenone Therapy in Chronic Central Serous Chorioretinopathy:A Prospective, Open-Label Pilot Clinical Study.
    Rajesh B; Agrawal H; Peguda HK; Chhablani J
    Ophthalmic Surg Lasers Imaging Retina; 2018 Jul; 49(7):479-486. PubMed ID: 30021034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study.
    Bousquet E; Beydoun T; Zhao M; Hassan L; Offret O; Behar-Cohen F
    Retina; 2013; 33(10):2096-102. PubMed ID: 23719402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study.
    Schwartz R; Habot-Wilner Z; Martinez MR; Nutman A; Goldenberg D; Cohen S; Shulman S; Guzner-Gur H; Loewenstein A; Goldstein M
    Acta Ophthalmol; 2017 Nov; 95(7):e610-e618. PubMed ID: 28653813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OCT Angiography Compared to Fluorescein and Indocyanine Green Angiography in Chronic Central Serous Chorioretinopathy.
    Teussink MM; Breukink MB; van Grinsven MJ; Hoyng CB; Klevering BJ; Boon CJ; de Jong EK; Theelen T
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5229-37. PubMed ID: 26244299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal Pigment Epithelial Features in Central Serous Chorioretinopathy Identified by Polarization-Sensitive Optical Coherence Tomography.
    Roberts P; Baumann B; Lammer J; Gerendas B; Kroisamer J; Bühl W; Pircher M; Hitzenberger CK; Schmidt-Erfurth U; Sacu S
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1595-603. PubMed ID: 27046123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone - a case report.
    Venkatesh R; Pereira A; Jain K; Yadav NK
    BMC Ophthalmol; 2020 Jun; 20(1):219. PubMed ID: 32503484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography.
    Quaranta-El Maftouhi M; El Maftouhi A; Eandi CM
    Am J Ophthalmol; 2015 Sep; 160(3):581-587.e1. PubMed ID: 26133250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
    Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ
    Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal Imaging and Choroidal Volumetric Changes After Half-fluence PDT in Central Serous Chorioretinopathy.
    Munk MR; Shah R; Pappas F; Baddar D; Wong B; Jampol LM; Fawzi AA
    Curr Eye Res; 2016; 41(1):97-106. PubMed ID: 25612245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY IN CENTRAL SEROUS CHORIORETINOPATHY.
    Chan SY; Wang Q; Wei WB; Jonas JB
    Retina; 2016 Nov; 36(11):2051-2058. PubMed ID: 27164548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central serous chorioretinopathy induced by drugs metabolized by cytochrome P450 3A4.
    Morawski K; Klonowska A; Kubicka-Trzaska A; Woron J; Romanowska-Dixon B
    J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32776913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy.
    Nicolò M; Zoli D; Musolino M; Traverso CE
    Am J Ophthalmol; 2012 Mar; 153(3):474-480.e1. PubMed ID: 22019224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-year follow-up of choroidal neovascularisation in eyes of chronic central serous chorioretinopathy.
    Chen YC; Chen SN
    Br J Ophthalmol; 2020 Nov; 104(11):1561-1566. PubMed ID: 32051140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central serous chorioretinopathy: risk factors for serous retinal detachment in fellow eyes.
    Shinojima A; Mehanna C; Lavia CA; Gaudric A; Tadayoni R; Bousquet E
    Br J Ophthalmol; 2020 Jun; 104(6):852-856. PubMed ID: 31473627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Cheng CK; Chang CK; Peng CH
    Retina; 2017 Feb; 37(2):325-333. PubMed ID: 27429374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.